Abstract:The aim of the study was to investigate the risk factors of preprocedural laboratory investigations and drug effects to the incidence of contrast-induced nephropathy (CIN) in patients with diabetes who underwent coronary angiography or percutaneous coronary intervention and to assess the short-term safety. We retrospectively studied a total of 568 patients with diabetes who underwent coronary angiography or percutaneous coronary intervention from January, 2013 to January, 2014 in our hospital and compared the baseline clinical characteristics, especially the laboratory investigations and preprocedural drugs of those 2 groups (with CIN group and without CIN group), and half year follow-up. Overall, 53 (9.33%) patients were developed into CIN according to the definition of an increase of 25% from the baseline of serum creatinine concentration, supposing that on the basis of an increase of 44.2 μmol/L, the incidence would be 0.88% (5/568). No significant differences were found between the 2 groups with respect to age, diabetes mellitus duration, operation type, contrast type and volume, left ventricular ejection fraction, and combined diseases including hypertension, myocardial infarction, Arrhythmia, etc. However, patients with CIN tended to be lighter in body weight (P = 0.027) and were more often female [odds ratio (OR) = 2.8, P < 0.01], and also had a higher prevalence with acute coronary syndrome (OR = 5.1, P < 0.01). On the contrary to most studies, the preprocedural serum creatinine in with CIN group in our study was lower than without CIN group (P < 0.001). As for the preprocedural drugs, statins seemed could decrease the incidence of CIN (OR = 0.34, P < 0.05), and the use of diuretics might increase the occurrence of CIN (OR = 2.62, P < 0.05). As regard to the follow-up results, the hospitalization days and expense of with CIN group were significantly longer and higher than the without CIN group, but no significance was found between rehospitalization rate in half year. Preprocedural preventions are essential because there is no effective treatment for CIN our findings could be considered in clinical practice. There are many risk factors for CIN; it is necessary to distinguish the high-risk patients so as to carry out corresponding protection actions.

Evaluation of contrast induced nephropathy related risk factors and long‐term results

Clinical study of contrast induced nephropathy in patients undergoing coronary intervention.

Clinical Study of Contrast-induced Nephropathy in Inpatients in Cardiology Department After Coronaryartery Intervention

Clinical Survey on Contrast-Induced Nephropathy after Coronary Angiography.

Contrast-induced nephropathy in interventional cardiology

Drug Effects and Clinical Investigations for Contrast-Induced Nephropathy after Coronary Angiography or Percutaneous Coronary Intervention in Patients with Diabetes.

Predictive value of post-procedural hyponatremia on contrast-induced nephropathy in patients who underwent coronary angiography or percutaneous coronary intervention

A Multi-Center Clinical Study of Contrast-Induced Nephropathy in Inpatients in Cardiology Department after Coronary Artery Intervention

Effect of the low-osmolality nonionic contrast media on renal function in patients undergoing coronary intervention: a prospective study

Close and long-term effects of the patients with contrast induced nephropathy after percutaneous coronary intervention

Evaluating biomarkers for contrast-induced nephropathy following coronary interventions: an umbrella review on meta-analyses

Evaluating the Differential Risk of Contrast-Induced Nephropathy Among Diabetic and Non-diabetic Patients Following Percutaneous Coronary Intervention

Contrast-induced Nephropathy in 532 Patients Undergoing Coronary Intervention

Evaluation of Emerging Predictors for Contrast-Induced Nephropathy in High-Risk Patients Undergoing Percutaneous Coronary Intervention

[Early prevention progress of contrast induced nephropathy]

Clinical Outcomes of Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention: A Prospective, Multicenter, Randomized Study to Analyze the Effect of Hydration and Acetylcysteine

Contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention

Investigation of Risk Factors of Contrast-Induced Nephropathy in Multi-centers after Coronary Artery Intervention

Could serum cystatin C be employed in diagnosing contrast-induced nephropathy after nonemergency endovascular therapy with peripheral arterial diseases?

Contrast-Induced Nephropathy: A Review of Mechanisms and Risks

Obesity as a Risk Factor for Radiographic Contrast-Induced Nephropathy